Portuguese researchers identified a type of immune cell that appears to travel to the pancreas to stimulate glucagon ...

A recent study published in Diabetologia has identified insulinoma-associated protein 2 autoantibody (IA-2A) positivity as a ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to ...

Willem Linders received some bad news in September 2024: pancreatic cancer. His illness is incurable. Nevertheless, the ...

Gastrointestinal involvement is common among patients with EGPA, with eosinophilic tissue infiltration, weight loss, and myalgia identified as significant predictors.

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

A study from the University of Utah Health suggests early antibiotic use may disrupt insulin-producing beta cells, increasing the risk of metabolic disorders like type 1 diabetes.

Silexion's SIL204 reduced tumor growth and metastases in pancreatic cancer models, showing strong efficacy across KRAS mutation profiles in preclinical studies.

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

"ReShape's Diabetes Neuromodulation technology regulates blood glucose by selectively modulating vagal block and stimulation ...

A Columbia University dermatologist argues that physicians in her specialty should be on the lookout for metabolic syndrome ...